Taizhou Municipal Hospital Researchers Provide New Study Findings on Spinal Cord Injury (Screening strategy identified idebenone loaded ROS-responsive nano-polyphenolic vesicle for spinal cord injury therapy).

Researchers at Taizhou Municipal Hospital in China have conducted a study on spinal cord injury (SCI) and identified a potential therapy. The study found that oxidative stress is a major factor in SCI and can lead to mitochondrial damage, ferroptosis, and apoptosis in neural cells. The researchers developed a multifunctional nanovesicle called IDE@PPNs, which contains idebenone and proanthocyanidin polyphenol nanovesicles. In animal studies, IDE@PPNs promoted motor function recovery and suppressed ferroptosis and apoptosis in neurons. The researchers concluded that IDE@PPNs have great potential for SCI therapy. [Extracted from the article]

Copyright of Pain & Central Nervous System Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)